Published in Gene Therapy Weekly, March 23rd, 2000
"Tissue factor pathway inhibitor (TFPI) is an endogenous inhibitor of factor Xa and the coagulant initiator complex tissue factor/factor VIIa," stated P. Zoldhelyi and colleagues from the Texas Heart Institute, Texas, USA. "We sought to study the effects of TFPI gene transfer on thrombus formation."
Zoldhelyi et al. published the results of their study in Circulation ("Thromboresistance of balloon-injured porcine carotid arteries after local gene...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.